97 related articles for article (PubMed ID: 33987037)
1. A novel one-step quick assay for detection of SARS-COV2 antibodies across mammalian species.
Zhou X
PeerJ; 2021; 9():e11381. PubMed ID: 33987037
[TBL] [Abstract][Full Text] [Related]
2. Development and clinical application of a rapid IgM-IgG combined antibody test for SARS-CoV-2 infection diagnosis.
Li Z; Yi Y; Luo X; Xiong N; Liu Y; Li S; Sun R; Wang Y; Hu B; Chen W; Zhang Y; Wang J; Huang B; Lin Y; Yang J; Cai W; Wang X; Cheng J; Chen Z; Sun K; Pan W; Zhan Z; Chen L; Ye F
J Med Virol; 2020 Sep; 92(9):1518-1524. PubMed ID: 32104917
[TBL] [Abstract][Full Text] [Related]
3. Rapid and Sensitive Detection of anti-SARS-CoV-2 IgG, Using Lanthanide-Doped Nanoparticles-Based Lateral Flow Immunoassay.
Chen Z; Zhang Z; Zhai X; Li Y; Lin L; Zhao H; Bian L; Li P; Yu L; Wu Y; Lin G
Anal Chem; 2020 May; 92(10):7226-7231. PubMed ID: 32323974
[TBL] [Abstract][Full Text] [Related]
4. Four point-of-care lateral flow immunoassays for diagnosis of COVID-19 and for assessing dynamics of antibody responses to SARS-CoV-2.
Wu JL; Tseng WP; Lin CH; Lee TF; Chung MY; Huang CH; Chen SY; Hsueh PR; Chen SC
J Infect; 2020 Sep; 81(3):435-442. PubMed ID: 32553841
[TBL] [Abstract][Full Text] [Related]
5. Two serological approaches for detection of antibodies to SARS-CoV-2 in different scenarios: a screening tool and a point-of-care test.
Hoste ACR; Venteo A; Fresco-Taboada A; Tapia I; Monedero A; López L; Jebbink MF; Pérez-Ramírez E; Jimenez-Clavero MA; Almonacid M; Muñoz P; Guinea J; Vela C; van der Hoek L; Rueda P; Sastre P
Diagn Microbiol Infect Dis; 2020 Dec; 98(4):115167. PubMed ID: 32890908
[TBL] [Abstract][Full Text] [Related]
6. HCoV-NL63 and SARS-CoV-2 Share Recognized Epitopes by the Humoral Response in Sera of People Collected Pre- and during CoV-2 Pandemic.
Simula ER; Manca MA; Jasemi S; Uzzau S; Rubino S; Manchia P; Bitti A; Palermo M; Sechi LA
Microorganisms; 2020 Dec; 8(12):. PubMed ID: 33327507
[TBL] [Abstract][Full Text] [Related]
7. A 10-Minute "Mix and Read" Antibody Assay for SARS-CoV-2.
Rusanen J; Kareinen L; Levanov L; Mero S; Pakkanen SH; Kantele A; Amanat F; Krammer F; Hedman K; Vapalahti O; Hepojoki J
Viruses; 2021 Jan; 13(2):. PubMed ID: 33498157
[TBL] [Abstract][Full Text] [Related]
8. Assessment of SARS-CoV-2 serological tests for the diagnosis of COVID-19 through the evaluation of three immunoassays: Two automated immunoassays (Euroimmun and Abbott) and one rapid lateral flow immunoassay (NG Biotech).
Nicol T; Lefeuvre C; Serri O; Pivert A; Joubaud F; Dubée V; Kouatchet A; Ducancelle A; Lunel-Fabiani F; Le Guillou-Guillemette H
J Clin Virol; 2020 Aug; 129():104511. PubMed ID: 32593133
[TBL] [Abstract][Full Text] [Related]
9. Evaluating the longitudinal effectiveness of preventive measures against COVID-19 and seroprevalence of IgG antibodies to SARS-CoV-2 in cancer outpatients and healthcare workers.
Fong D; San Nicolò KO; Alber M; Mitterer M
Wien Klin Wochenschr; 2021 Apr; 133(7-8):359-363. PubMed ID: 33502609
[TBL] [Abstract][Full Text] [Related]
10. Novel rapid immunochromatographic test based on an enzyme immunoassay for detecting nucleocapsid antigen in SARS-associated coronavirus.
Kogaki H; Uchida Y; Fujii N; Kurano Y; Miyake K; Kido Y; Kariwa H; Takashima I; Tamashiro H; Ling AE; Okada M
J Clin Lab Anal; 2005; 19(4):150-9. PubMed ID: 16025480
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of Three Commercial SARS-CoV-2 Serologic Assays and Their Performance in Two-Test Algorithms.
Turbett SE; Anahtar M; Dighe AS; Garcia Beltran W; Miller T; Scott H; Durbin SM; Bharadwaj M; Thomas J; Gogakos TS; Astudillo M; Lennerz J; Rosenberg ES; Branda JA
J Clin Microbiol; 2020 Dec; 59(1):. PubMed ID: 33020186
[TBL] [Abstract][Full Text] [Related]
12. Development and clinical application of a rapid SARS-CoV-2 antibody test strip: A multi-center assessment across China.
Liao M; Yan J; Wang X; Qian H; Wang C; Xu D; Wang B; Yang B; Liu S; Zhou M; Gao Q; Zhou Q; Luo J; Li Z; Liu W
J Clin Lab Anal; 2021 Jan; 35(1):e23619. PubMed ID: 33067888
[TBL] [Abstract][Full Text] [Related]
13. Early Detection of Severe Acute Respiratory Syndrome Coronavirus 2 Antibodies as a Serologic Marker of Infection in Patients With Coronavirus Disease 2019.
Rongqing Z; Li M; Song H; Chen J; Ren W; Feng Y; Gao GF; Song J; Peng Y; Su B; Guo X; Wang Y; Chen J; Li J; Sun H; Bai Z; Cao W; Zhu J; Zhang Q; Sun Y; Sun S; Mao X; Su J; Chen X; He A; Gao W; Jin R; Jiang Y; Sun L
Clin Infect Dis; 2020 Nov; 71(16):2066-2072. PubMed ID: 32357209
[TBL] [Abstract][Full Text] [Related]
14. Heterogeneous antibodies against SARS-CoV-2 spike receptor binding domain and nucleocapsid with implications for COVID-19 immunity.
McAndrews KM; Dowlatshahi DP; Dai J; Becker LM; Hensel J; Snowden LM; Leveille JM; Brunner MR; Holden KW; Hopkins NS; Harris AM; Kumpati J; Whitt MA; Lee JJ; Ostrosky-Zeichner LL; Papanna R; LeBleu VS; Allison JP; Kalluri R
JCI Insight; 2020 Sep; 5(18):. PubMed ID: 32796155
[TBL] [Abstract][Full Text] [Related]
15. Rapid Detection of IgM Antibodies against the SARS-CoV-2 Virus via Colloidal Gold Nanoparticle-Based Lateral-Flow Assay.
Huang C; Wen T; Shi FJ; Zeng XY; Jiao YJ
ACS Omega; 2020 Jun; 5(21):12550-12556. PubMed ID: 32542208
[TBL] [Abstract][Full Text] [Related]
16. Coronavirus-Associated Coagulopathy: Lessons From SARS-CoV1 and MERS-CoV for the Current SARS-CoV2 Pandemic.
Singh S; Zuwasti U; Haas C
Cureus; 2020 Nov; 12(11):e11310. PubMed ID: 33282586
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of performance of two SARS-CoV-2 Rapid IgM-IgG combined antibody tests on capillary whole blood samples from the fingertip.
Prazuck T; Colin M; Giachè S; Gubavu C; Seve A; Rzepecki V; Chevereau-Choquet M; Kiani C; Rodot V; Lionnet E; Courtellemont L; Guinard J; Pialoux G; Hocqueloux L
PLoS One; 2020; 15(9):e0237694. PubMed ID: 32941461
[TBL] [Abstract][Full Text] [Related]
18. Development of a SARS-CoV-2-specific biosensor for antigen detection using scFv-Fc fusion proteins.
Kim HY; Lee JH; Kim MJ; Park SC; Choi M; Lee W; Ku KB; Kim BT; Changkyun Park E; Kim HG; Kim SI
Biosens Bioelectron; 2021 Mar; 175():112868. PubMed ID: 33281048
[TBL] [Abstract][Full Text] [Related]
19. SARS-CoV-2 Coronavirus Nucleocapsid Antigen-Detecting Half-Strip Lateral Flow Assay Toward the Development of Point of Care Tests Using Commercially Available Reagents.
Grant BD; Anderson CE; Williford JR; Alonzo LF; Glukhova VA; Boyle DS; Weigl BH; Nichols KP
Anal Chem; 2020 Aug; 92(16):11305-11309. PubMed ID: 32605363
[TBL] [Abstract][Full Text] [Related]
20. Comparison of Two Automated Immunoassays for the Detection of SARS-CoV-2 Nucleocapsid Antibodies.
Hubbard JA; Geno KA; Khan J; Szczepiorkowski ZM; de Gijsel D; Ovalle AA; AlSalman AS; Gallagher TL; Johnston AA; Tibbetts AR; Vital SE; Cervinski MA; Nerenz RD
J Appl Lab Med; 2021 Mar; 6(2):429-440. PubMed ID: 32976593
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
